Active — Not RecruitingNot Applicable

Sphenopalatine Block vs Dexmedetomidine Infusion in Trans Nasal Endoscopic Pituitary Surgery

Egypt69 participantsStarted 2024-10-01

Plain-language summary

Improving pain and surgical field by using sphenopalatine ganglion block and dexmedetomidine in trans-nasal endoscopic pituitary surgery.

Who can participate

Age range21 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age: between 21-64 years old. * sex: males and females. * Body mass index: 35 kg/m2. * ASA Physical status: grade Ⅰ-Ⅱ. Exclusion Criteria: * patients receiving beta blockers, anti-coagulants and antihypertensive medications also patients receiving clonidine or benzodiazepines, neuroleptics or antidepressants two weeks prior to the study. * Any contraindication for regional anesthesia e.g. coagulopathy, infection at site of block and hypersensitivity to any drug used in this study. * Patients who are known to be drug addict.

What they're measuring

Postoperative pain using VAS scale.

Timeframe: 24hours

Surgical field using Average Category Scale (ACS).

Timeframe: 5hours

Trial details

NCT IDNCT06639659

SponsorZagazig University

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2026-10

View on ClinicalTrials.gov More Sphenopalatine Ganglion Nerve Block trials